News

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.
After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...
The end of production at one of pharmaceutical firm GlaxoSmithKline's (GSK) UK factories is a "sad day", a former worker has said.The site in Ulverston, Cumbria, opened more than 75 years ago and most ...
U.S. Senator Maggie Hassan has initiated an investigation into GlaxoSmithKline's decision to discontinue the Flovent HFA ...
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant ...
Senator Maggie Hassan launches an investigation into GlaxoSmithKline's withdrawal of a popular asthma inhaler, linking it to ...
Botanical Solution’s CEO Gaston Salinas declared, “We are very excited to welcome Eddie Gray to the Board. He is the perfect ...
GlaxoSmithKline share price has surged more than 36% in two sessions after the announcement of Q3 results. The stock has surged 27% in one month and over 17% on a year-to-date (YTD) basis.